HungerMgmt(tm) Balm is used topically in conjunction with any and all diets plans. It is the first of its kind developed neuroscientifically to strengthen willpower and minimizes cravings assuring successful dieting and weight loss.
PHILADELPHIA, PA / ACCESSWIRE / Olfactory Biosciences Corp. (OLFC) is pleased to introduce HungerMgmt™ Balm developed by Olfactory Biosciences using its own and NOBEL Prize winning science.
It is the first neuroscientific product of its kind and targets the olfactory receptor nerves, that trigger the hypothalamus, a part of the brain which is the main regulatory organ for the human appetite. http://hungermgmt.org/
Topical application under the nose of HungerMgmt(tm) special odorants that send signals, via the receptors, to the brain messaging that the stomach is full and therefore helps curb your cravings resulting in control of your diet and weight loss.
HungerMgmt(tm) uses advanced neuroscience and olfactory receptors (the only nerves in the body exposed to the environment) to effect the desired reduction in food intake. HungerMgmt(tm) is a direct route to the brain and controls proper dieting. http://hungermgmt.org/
From Nutrisystem to Weight Watchers and everything in between, HungerMgmt(tm) is like an insurance program curbing the cravings and minimizing impulse eating.
According to Dr. Gary Foster, Clinical Director of the University of Pennsylvania’s Weight and Eating Disorder Program, nearly 65% of dieters return to their pre-diet weight after one year. The statistics for crash dieters are even worse according to Wellsphere, a website sponsored by Stanford University. Only 5% of people who lose weight on crash diet will keep that weight off.
Now there is an affordable, effective way to make your diet a success and maintain weight loss over the long term. For more information about HungerMgmt™ and order information, go online at http://hungermgmt.org/
Ingredients: A special proprietary formulation of natural Phytonutrients and Phytochemicals taken from plants, flowers, roots and seeds.
About Olfactory Biosciences Corp.
Olfactory Biosciences Corp.'s NOXO division develops products targeting olfactory receptors in the nose for the desired effect. These alternative medicine wellness products can modify behavior or provide relief to common behavior challenges such as anxiety or help with weight control. http://www.noxoinfo.com/investor
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Richard Stevenson, PresidentOlfactory Biosciences Corp.333 E. Lancaster Ave. Suite 317Wynnewood, PA 19096, USAPhone: 484-278-1626E-mail: [email protected]Website: http://www.noxoinfo.com/
Source: Olfactory Biosciences Corp.